Jefferies analyst Stephen Volkmann upgraded Emerson (EMR) to Buy from Hold with a price target of $175, up from $160, after assuming coverage of the name. The firm says the company’s “strong” orders momentum should support an acceleration in its earnings growth from low-single-digits in the first half of the year to low-double-digits exiting fiscal 2026. In addition, Emerson has seen margin improvement, which will support higher valuation multiples, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson named short-term sell idea at Deutsche Bank
- Emerson initiated with a Market Perform at BMO Capital
- AI Daily: OpenAI said to work on alternative to GitHub
- AI in high-margin hardware should be concern to investors, says Barclays
- OpenAI’s ex-research chief targets AI-driven manufacturing automation, WSJ says